Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Schouw & Co. share buy-back programme, week 39 2024
-
Alliance Trust PLC - Net Asset Value
-
Vow ASA: Order intake confirms growing demand for renewable energy solutions for heat treatment solutions
-
ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
-
Ocuphire Pharma Announces Publication of Full Phase 3 Results of Phentolamine Ophthalmic Solution 0.75% for Pharmacologically-Induced Mydriasis in Ophthalmology
-
SDVerse Launches B2B Automotive Software Marketplace, an Industry First for Software-Defined Vehicles
-
Ultralife Corporation to Acquire Electrochem Solutions, Inc.
-
INmune Bio Inc. Completes Enrollment for Phase 2 Trial in Early Alzheimer's Disease
-
COUR Pharmaceuticals Announces Positive Top-line Results from Phase 2a Study of CNP-104 in Primary Biliary Cholangitis
-
Integer Holdings Corporation to Divest Non-Medical Business for $50 million
-
Madrigal Pharmaceuticals Announces Publication of Positive Health-Related Quality of Life Results from the Phase 3 MAESTRO-NASH Trial of Rezdiffra™ (resmetirom)
-
CareCloud and ChartSwap Partner to Launch "CareCloud Powered by ChartSwap" to Streamline the Request for Information Process
-
Galectin Therapeutics to Participate in the H.C. Wainwright MASH Conference
-
AEON Biopharma Announces Positive Outcome from FDA Biosimilar Advisory Meeting
-
The Oncology Institute of Hope & Innovation Launches Oregon Market
-
Provident Protection Plus Named a Top Performing Insurance Agency in the U.S. by the Independent Insurance Agents & Brokers of America
-
Nano Hearing Aids® Launches New Innovative "Completely in Canal" Hearing Aids
-
Avalyn Announces Upcoming Presentations on its Lead Program AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis at the 22nd International Colloquium on Lung and Airway Fibrosis
-
MBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual Meeting
-
Infinera’s Commitment to Emission Reduction Validated by Science Based Targets initiative
-
Seanergy Maritime Mails Letter to Shareholders Highlighting its Commitment to Delivering Value to All Shareholders
-
Steakholder Foods® Receives First Ever Purchase Order Under New Commercial Sales Agreement with Bondor Foods
-
LOBO EV Technologies Ltd. Announces H1 2024 Earnings with 49% Revenue Growth and 45% Increase in Units Sold
-
AMN Healthcare to Hold Third Quarter 2024 Earnings Conference Call on Thursday, November 7, 2024
-
Mattermost Appoints Matthew Heideman as Vice President of Public Sector to Lead Federal Growth Initiatives
-
Metavesco Acquires Assets From Epic Labor
-
LENZ Therapeutics Announces Presentations at Upcoming Ophthalmology and Optometry Medical Conferences
-
Annovis Files Three New Patents for Combination Therapies Involving Buntanetap, Trulicity, and Viagra
-
INmune Bio Inc. Completes Enrollment for Phase 2 Trial in Early Alzheimer's Disease
-
Korro Announces Oral and Poster Presentations at the 20th Annual Meeting of the Oligonucleotide Therapeutics Society
-
Matthews International Completes Senior Notes Offering
-
Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma
-
ShipperGuide TMS Named a Leader in the G2 Grid® for Transportation Management Systems
-
Adaptive Research Announces it has Begun Enrolling Patients in AriBio’s Phase 3 POLARIS-AD Clinical Trial
-
Superluminal Medicines Announces Formation of Scientific Advisory Board
-
Scorpius Holdings Announces Contract with Premier Clinical-Stage Biotech Company; Opens Door to Future GMP Manufacturing Opportunities
-
The Future is Now: Confronting Today’s Healthcare Challenges and Shaping Tomorrow’s Care at Empower
-
Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP Study
-
Epilepsy Foundation Awards $200,000 at 12th Annual Shark Tank Competition
-
Merus Announces First Patient Dosed in LiGeR-HN1, a Phase 3 Trial Evaluating Petosemtamab in Combination with Pembrolizumab in 1L r/m HNSCC
-
Nano Hearing Aids® Launches New Innovative "Completely in Canal" Hearing Aids
-
Redwood Logistics and LK® Packaging Dish Out Supply Chain Efficiency, Achieving Six-Figure Savings
-
Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024
-
IGI Announces CRADA with National Cancer Institute to Test Proprietary Oral Cbl/b Inhibitor Treatment in Triple Negative Breast Cancer
-
Aligos Therapeutics to Present at Investor Conferences in October
-
Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting
-
ManTech Releases Premier Open-Source Reference Architecture for Digital Engineering Environment
-
Shoals Technologies Group Appoints Chief Operations Officer and Interim Chief Legal Officer
-
Casella Waste Systems, Inc. Announces Closing of $1.5 Billon Amended and Restated Credit Facility
-
Wellinks Acquires Spire Health Creating Industry Leader in Predictive Patient Care for Cardiopulmonary Health
